⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for erbb1

Every month we try and update this database with for erbb1 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast CancerNCT00075270
Neoplasms, Brea...
Paclitaxel
GW572016 (Lapat...
18 Years - GlaxoSmithKline
Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast CancerNCT00075270
Neoplasms, Brea...
Paclitaxel
GW572016 (Lapat...
18 Years - GlaxoSmithKline
GW572016 With Docetaxel and Trastuzumab for the Treatment Of Untreated ErbB2 Over-Expressing Metastatic Breast CancerNCT00251433
Neoplasms, Brea...
lapatinib, doce...
18 Years - Novartis
GW572016 In Patients With Advanced Or Metastatic Breast CancerNCT00462956
Neoplasms, Brea...
Tykerb
20 Years - 40 YearsGlaxoSmithKline
ErbB2 Over-expressing Metastatic Breast Cancer Study Using Paclitaxel, Trastuzumab, and LapatinibNCT00272987
Neoplasms, Brea...
lapatinib
paclitaxel
trastuzumab
18 Years - Novartis
Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast CancerNCT00820222
Metastases, Bra...
capecitabine
lapatinib
trastuzumab
18 Years - Novartis
GW572016 In Patients With ErbB2 Over - Expressing Advanced Or Metastatic Breast CancerNCT00320411
Neoplasms, Brea...
lapatinib
20 Years - 74 YearsGlaxoSmithKline
GW572016 Combined With Trastuzumab For The Treatment Of Previously Trastuzumab-Treated Breast CancerNCT00371488
Neoplasms, Brea...
GW572016 oral t...
20 Years - 74 YearsGlaxoSmithKline
Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast CancerNCT00820222
Metastases, Bra...
capecitabine
lapatinib
trastuzumab
18 Years - Novartis
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: